Publications: Olynyk, John
Acikyol, B., Graham, R.M., Trinder, D., House, M.J., Olynyk, J.K., Scott, R.J., Milward, E.A. and Johnstone, D.M. (2013) Brain transcriptome perturbations in the transferrin receptor 2 mutant mouse support the case for brain changes in iron loading disorders, including effects relating to long-term depression and long-term potentiation. Neuroscience, 235 . pp. 119-128.
House, M.J., Gan, E.K., Adams, L.A., Ayonrinde, O.T., Bangma, S.J., Bhathal, P.S., Olynyk, J.K. and St. Pierre, T.G. (2013) Diagnostic performance of a rapid magnetic resonance imaging method of measuring hepatic steatosis. PLoS ONE, 8 (3). e59287.
Maker, G.L., Siva, B., Batty, K.T, Trengove, R.D., Ferrari, P. and Olynyk, J.K. (2013) Pharmacokinetics and safety of deferasirox in subjects with chronic kidney disease undergoing haemodialysis. Nephrology, 18 (3). pp. 188-193.
Chalmers, K.A., Knuiman, M.W., Divitini, M.L., Bruce, D.G., Olynyk, J.K. and Milward, E.A. (2012) Long-term mortality risks associated with mild anaemia in older persons: the Busselton Health Study. Age and Ageing, 41 (6). pp. 759-764.
Gay, M.C.L., Mullaney, I., Trinder, D., Olynyk, J.K. and Trengove, R.D. (2010) Quantitative assay of urinary hepcidin using MALDI-TOF mass spectrometry. Analytical Methods, 2 (3). pp. 268-274.
Graham, R.M., Reutens, G.M., Herbison, C.E., Delima, R.D., Chua, A.C.G., Olynyk, J.K. and Trinder, D. (2008) Transferrin receptor 2 mediates uptake of transferrin-bound and non-transferrin-bound iron. Journal of Hepatology, 48 (2). pp. 327-334.